Last reviewed · How we verify

NCT05503589

The Psychological Effect of the Covid-19 Pandemic

Completed Last updated 6 March 2025
What this trial tests

trial in Psychological Distress in 66 participants. Completed in 30 April 2021.

Timeline
1 March 2021
Primary endpoint
26 April 2021
30 April 2021

Quick facts

Lead sponsorKutahya Health Sciences University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment66
Start date1 March 2021
Primary completion26 April 2021
Estimated completion30 April 2021
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Kutahya Health Sciences University

Who can join

Adults 18 to 30, any sex, with Psychological Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At the end of 2019, the novel coronavirus disease (Covid-19), which emerged in China, has become a public health emergency of international concern. Disease outbreaks both affect the physical and psychological health of individuals. The aim of this study was to investigate the levels of stress, anxiety, depression, and Covid-19 fear in health sciences intern students during the Covid-19 pandemic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Psychological Distress

Currently open trials in the same condition.

Other Kutahya Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing